Genoox raises $6M to make genetic data analysis more accessible for clinics

Genoox’s current platform can examine data from both whole-genome sequencing (WGS), which sequences all the base pairs in a genome at one time, as well as whole-exome sequencing (WES), a less costly alternative to whole-genome sequencing that sequences exons, which make up about one percent of the human genome.

Categorised in: Uncategorized

This post was written by admin